Exothera appoints Darren Leva as Chief Business Officer
Exothera, a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, and oncolytic viruses, has appointed Darren Leva as Chief Business Officer. Darren’s extensive commercial experience in biotherapeutics CDMOs will further extend Exothera’s business and commercial capability across existing and brand-new markets.
Darren brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies. Most recently, he held leadership positions in Cell and Gene Therapy at Thermo Fisher Scientific while also being deeply involved in the manufacturing response to the Covid-19 pandemic. As Head of Commercial Operations, he helped build and lead both GMP Plasmid and GMP Cell Therapy businesses. Darren’s diverse experiences in the software industry has helped him develop a deep understanding of datadriven processes, which, combined with Univercells’ unique technologies and bioprocessing capabilities, will help Exothera realize its vision of making cell & gene therapy available to all.
Darren Leva, new Chief Business Officer at Exothera